Natco Pharma gains on making strategic investment in ISCA Inc
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Natco Pharma is currently trading at Rs. 911.00, up by 6.60 points or 0.73% from its previous closing of Rs. 904.40 on the BSE.
The scrip opened at Rs. 918.35 and has touched a high and low of Rs. 918.35 and Rs. 899.90 respectively. So far 9278 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 920.00 on 10-Aug-2023 and a 52 week low of Rs. 502.00 on 02-Feb-2023.
Last one week high and low of the scrip stood at Rs. 918.35 and Rs. 873.90 respectively. The current market cap of the company is Rs. 16268.55 crore.
The promoters holding in the company stood at 49.76%, while Institutions and Non-Institutions held 26.17% and 24.07% respectively.
Natco Pharma has made strategic investment in ISCA, Inc., a Delaware Corporation, which had a turnover of $9.3 million in the last fiscal year ending in December 2022. Cost of acquisition is $2 million. The company has made strategic investment for bio control of pest.
Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.
